Genes Chromosomes & Cancer

Article	Citations
Emerging soft tissue tumors with kinase fusions: An overview of the recent literature with an emphasis on diagnostic criteria	67
Soft tissue tumors characterized by a wide spectrum of kinase fusions share a lipofibromatosis‐like neural tumor pattern	56
PARP inhibitors in ovarian cancer: An overview of the practice‐changing trials	49
Mismatch repair deficiency: The what, how and why it is important	45
Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias	43
Analysis of mutational signatures with yet another package for signature analysis	38
Translocation carcinomas of the kidney	35
The clinical heterogeneity of round cell sarcomas with EWSR1/FUS gene fusions: Impact of gene fusion type on clinical features and outcome	34
NTRK and other recently described kinase fusion positive uterine sarcomas: A review of a group of rare neoplasms	29
DICER1‐associated embryonal rhabdomyosarcoma and adenosarcoma of the gynecologic tract: Pathology, molecular genetics, and indications for molecular testing	28
Fusion‐positive non‐small cell lung carcinoma: Biological principles, clinical practice, and diagnostic implications	28
Comprehensive targeted next‐generation sequencing approach in the molecular diagnosis of gastrointestinal stromal tumor	27
NTRK testing: First results of the QuiP‐EQA scheme and a comprehensive map of NTRK fusion variants and their diagnostic coverage by targeted RNA‐base	27
Epithelioid hemangioma of bone harboring FOS and FOSB gene rearrangements: A clinicopathologic and molecular study	27
NovelPPP1CB‐ALKfusion in spindle cell tumor defined by S100 and CD34 coexpression and distinctive stromal and perivascular hyalinization	24
Molecular pathogenesis and prognostication of "low‐grade'' and "high‐grade" endometrial stromal sarcoma	24
A novel CLTC‐FOSB gene fusion in pseudomyogenic hemangioendothelioma of bone	22
Impact of immunophenotypic characteristics on genetic subgrouping in childhood acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) study L04‐16	21
Perivascular epithelioid cell tumors (PEComa) of the gynecologic tract	20
Functional mechanisms of miR‐192 family in cancer	20
Wholistic approach: Transcriptomic analysis and beyond using archival material for molecular diagnosis	19
Novel morphological and genetic features of fumarate hydratase deficient renal cell carcinoma in HLRCC syndrome patients with a tailored therapeutic approach	18
Variability in retinoblastoma genome stability is driven by age and not heritability	18
Methylation classifiers: Brain tumors, sarcomas, and what's next	17
Novel fusion genes in spindle cell rhabdomyosarcoma: The spectrum broadens	17

Homologous recombination deficiency in breast cancer: Implications for risk, cancer development, and therapy	17
Homologous recombination repair deficiency (HRD): From biology to clinical exploitation	16
A novel MBTD1‐PHF1 gene fusion in endometrial stromal sarcoma: A case report and literature review	16
Hereditary leiomyomatosis and renal cell carcinoma syndrome associated uterine smooth muscle tumors: Bridging morphology and clinical screening	16
Undifferentiated round cell sarcomas with novel SS18‐POU5F1 fusions	15
Pediatric fibromyxoid soft tissue tumor with PLAG1 fusion: A novel entity?	15
Patterns of chromosome 18 loss of heterozygosity in multifocal ileal neuroendocrine tumors	15
An update of molecular findings in uterine tumor resembling ovarian sex cord tumor and GREB1‐rearranged uterine sarcoma with variable sex‐cord differentiation	15
Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicine	15
Characterization of TERT and BRAF copy number variation in papillary thyroid carcinoma: An analysis of the cancer genome atlas study	15
Activating genomic alterations in the Gs alpha gene (GNAS) in 274 694 tumors	14
Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP‐BFM acute lymphoblastic leukemia protocol	14
Uterine inflammatory myofibroblastic tumor: First report of a ROS1 fusion	14
Aggressive morphologic variants of mantle cell lymphoma characterized with high genomic instability showing frequent chromothripsis, CDKN2A/B loss, and TP53 mutations: A multi‐in	14
A low‐grade malignant soft tissue tumor with S100 and CD34 co‐expression showing novel CDC42SE2‐BRAF fusion with distinct features	14
Recent advances in smooth muscle tumors with PGR and PLAG1 gene fusions and myofibroblastic uterine neoplasms	14
Targeted next generation sequencing of MLH1‐deficient, MLH1 promoter hypermethylated, and BRAF/RAS‐wild‐type colorectal adenocarcinomas	14
Recurrent VGLL3 fusions define a distinctive subset of spindle cell rhabdomyosarcoma with an indolent clinical course and striking predilection for the head and neck	14
GAB1‐ABL1 fusions in tumors that have histologic overlap with NTRK‐rearranged spindle cell tumors	13
SMARCA2‐NR4A3 is a novel fusion gene of extraskeletal myxoid chondrosarcoma identified by RNA next‐generation sequencing	13
Update on SWI/SNF‐related gynecologic mesenchymal neoplasms: SMARCA4‐deficient uterine sarcoma and SMARCB1‐deficient vulvar neoplasms	13
KRAS/GNAS‐testing by highly sensitive deep targeted next generation sequencing improves the endoscopic ultrasound‐guided workup of suspected mucinous neoplasms of the pancreas	13
Characterization of unusual iAMP21 B‐lymphoblastic leukemia (iAMP21‐ALL) from the Mayo Clinic and Children's Oncology Group	13
Primary myxoid and epithelioid mesenchymal tumor of the kidney with a novel GLI1‐FOXO4 fusion	12
Gastroblastoma with a novel EWSR1‐CTBP1 fusion presenting in adolescence	12
PLAG1‐rearrangement in a uterine leiomyosarcoma with myxoid stroma and heterologous differentiation	12
Molecular prognostication of uterine smooth muscle neoplasms: From CGH array to CINSARC signature and beyond	12
MYB rearrangements and over‐expression in T‐cell acute lymphoblastic leukemia	12
A genome‐wide study of the relationship between chromosomal abnormalities and gene expression in colorectal tumors	12
Recurrent PTBP1::MAML2 fusions in composite hemangioendothelioma with neuroendocrine differentiation: A report of two cases involving neck lymph nodes	11
A unique epithelioid vascular neoplasm of bone characterized by EWSR1/FUS‐NFATC1/2 fusions	11
Poly(ADP‐ribose) polymerase inhibition in pancreatic cancer	11
Gastrointestinal stromal tumors with BRAF gene fusions. A report of two cases showing low or absent KIT expression resulting in diagnostic pitfalls	11
Central nervous system sarcoma with ATXN1::DUX4 fusion expands the concept of CIC‐rearranged sarcoma	11
Expanding the clinicopathological spectrum of TGFBR3‐PLAG1 rearranged salivary gland neoplasms with myoepithelial differentiation including evidence of high‐grade transformation	11
Pathogenic germline variants in patients with features of hereditary renal cell carcinoma: Evidence for further locus heterogeneity	10
Targeted RNA sequencing in the routine clinical detection of fusion genes in salivary gland tumors	10
Single nucleotide polymorphism array‐based signature of low hypodiploidy in acute lymphoblastic leukemia	10
MammaPrint and BluePrint comprehensively capture the cancer hallmarks in early‐stage breast cancer patients	10
Balanced and unbalanced translocations in a multicentric series of 2843 patients with chronic lymphocytic leukemia	10
RREB1‐MKL2 fusion in a spindle cell sinonasal sarcoma: biphenotypic sinonasal sarcoma or ectomesenchymal chondromyxoid tumor in an unusual site?	10
CARMN‐NOTCH2 fusion transcript drives high NOTCH2 expression in glomus tumors of the upper digestive tract	10
Detection of MEAF6‐PHF1 translocation in an endometrial stromal nodule	10
Fusion‐associated carcinomas of the breast: Diagnostic, prognostic, and therapeutic significance	10
Single‐cell sequencing in translational cancer research and challenges to meet clinical diagnostic needs	10
Germline MUTYH mutations and high‐grade gliomas: Novel evidence for a potential association	9
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype‐definition in small cell lung cancer	9
Sarcomas with sclerotic epithelioid phenotype harboring novel EWSR1‐SSX1 fusions	9
Spindle cell neoplasm with EML4‐ALK gene fusion presenting as an intraosseous vertebral mass	9
Poorly differentiated chordoma with whole‐genome doubling evolving from a SMARCB1‐deficient conventional chordoma: A case report	9

Characterization of genetically defined sporadic and hereditary type 1 papillary renal cell carcinoma cell lines	9
Sclerosing TSC1 mutated renal cell carcinoma: An unusual pattern mimicking MITF family translocation renal cell carcinoma	9
Analysis of 11 candidate genes in 849 adult patients with suspected hereditary cancer predisposition	9
MLLT10 rearranged acute leukemia: Incidence, prognosis, and possible therapeutic strategies	9
Novel morphologic findings in PLAG1‐rearranged soft tissue tumors	9
Dedifferentiated secretory breast carcinoma with fibrosarcomatous features harboring an ETV6‐NTRK3 fusion in both components	9
Immuno‐oncology gene expression profiling of formalin‐fixed and paraffin‐embedded clear cell renal cell carcinoma: Performance comparison of the NanoString nCounter technology with targeted	9
Clinicopathologic and survival correlates of embryonal rhabdomyosarcoma driven by RAS/RAF mutations	8
Activation of PLAG1 and HMGA2 by gene fusions involving the transcriptional regulator gene NFIB	8
Chromosomal instability upregulates interferon in acute myeloid leukemia	8
Prognostic significance of the MDM2/HMGA2 ratio and histological tumor grade in dedifferentiated liposarcoma	8
Fusion‐positive salivary gland carcinomas	8
A novel BRD4‐LEUTX fusion in a pediatric sarcoma with epithelioid morphology and diffuse S100 expression	8
Novel CTNND2‐TERT fusion in a spindle cell liposarcoma	8
Identification of tumors with NRG1 rearrangement, including a novel putative pathogenic UNC5D‐NRG1 gene fusion in prostate cancer by data‐drilling a de‐identified t	8
Quantification of NG2‐positivity for the precise prediction of KMT2A gene rearrangements in childhood acute leukemia	8
BRAF V600E and previously unidentified KRAS G12C mutations in odontogenic tumors may affect MAPK activation differently depending on tumor type	8
RREB1::MRTFB fusion‐positive extra‐glossal mesenchymal neoplasms: A series of five cases expanding their anatomic distribution and highlighting significant morphological and phenotypic diversit	8
Digenic inheritance of MSH6 and MUTYH variants in familial colorectal cancer	8
Recurrent loss of chromosome 22 and SMARCB1 deletion in extra‐axial chordoma: A clinicopathological and molecular analysis	8
Germline testing for homologous recombination repair genes—opportunities and challenges	7
Molecular analysis of 10 pleomorphic rhabdomyosarcomas reveals potential prognostic markers and druggable targets	7
EWSR1::YY1 fusion positive peritoneal epithelioid mesothelioma harbors mesothelioma epigenetic signature: Report of 3 cases in support of an emerging entity	7
Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR‐ABL1, a Swedish population‐based study	7
Survey of germline variants in cancer‐associated genes in young adults with colorectal cancer	7
Expanding the spectrum of GLI1‐altered mesenchymal tumors—A high‐grade uterine sarcoma harboring a novel PAMR1::GLI1 fusion and literature review of GLI1‐altered mesenchyma	7
N‐terminus DUX4‐immunohistochemistry is a reliable methodology for the diagnosis of DUX4‐fused B‐lymphoblastic leukemia/lymphoma (N‐terminus DUX4 IHC for DUX4<	7
Sustained remission after ruxolitinib and chimeric antigen receptor T‐cell therapy bridged to a second allogeneic hematopoietic stem cell transplantation for relapsed Philadelphia chromosome‐like B‐ce	7
ALK‐rearranged Mesenchymal Neoplasms: A Report of 9 cases Further Expanding the Clinicopathologic Spectrum of Emerging Kinase Fusion Positive Group of Tumors	7
Gene fusions characterize a subset of uterine cellular leiomyomas	7
Advances in sarcoma molecular diagnostics	7
Clonal dynamics in a composite chronic lymphocytic leukemia and hairy cell leukemia‐variant	7
Molecular investigation of ALK‐rearranged epithelioid fibrous histiocytomas identifies CLTC as a novel fusion partner and evidence of fusion‐independent transcripti	7
Typical, atypical and cryptic t(15;17)(q24;q21) (PML::RARA) observed in acute promyelocytic leukemia: A retrospective review of 831 patients with concurrent chromosome and PML::RARA dual	7
Clinicopathological features and resistance mechanisms in HIP1‐ALK‐rearranged lung cancer: A multicenter study	7
Successful treatment with MEK‐inhibitor in a patient with NRAS‐related cutaneous skeletal hypophosphatemia syndrome	6
A novel SMARCA2‐CREM fusion expending the molecular spectrum of salivary gland hyalinazing clear cell carcinoma beyond the FET genes	6
The presence of a chromosomal abnormality in cytopenia without dysplasia identifies a category of high‐risk clonal cytopenia of unknown significance	6
Mesenchymal chondrosarcoma of the head and neck with HEY1::NCOA2 fusion: A clinicopathologic and molecular study of 13 cases with emphasis on diagnostic pitfalls	6
Comparison of myeloid neoplasms with nonclassic 3q26.2/MECOM versus classic inv(3)/t(3;3) rearrangements reveals diverse clinicopathologic features, genetic profile	6
Hyalinizing epithelioid tumors with OGT‐FOXO fusions. A case report of a non‐acral soft tissue mass harboring a novel FOXO4 gene rearrangement	6
High‐risk cytogenetics in multiple myeloma: Further scrutiny of deletions within the IGH gene region enhances risk stratification	6
Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatments	6
Recurrent NF1 gene variants and their genotype/phenotype correlations in patients with Neurofibromatosis type I	6
Novel EWSR1::UBP1 fusion expands the spectrum of spindle cell rhabdomyosarcomas	6
Undifferentiated sarcoma of bone with a round to epithelioid cell phenotype harboring a novel EWSR1‐SSX2 fusion identified by RNA‐based next‐generation sequencing	6
Quantitative assessment of copy number alterations by liquid biopsy for neuroblastoma	6
Genomic and transcriptomic characterization of desmoplastic small round cell tumors	6
Insertion of an SVA element in MSH2 as a novel cause of Lynch syndrome	6
Identification of a novel KMT2A/GIMAP8 gene fusion in a pediatric patient with acute undifferentiated leukemia	5
Principles of molecular testing for hereditary cancer	5
Pediatric lipoblastoma with a novel EEF1A1‐PLAG1 fusion	5
Inflammatory leiomyosarcoma/rhabdomyoblastic tumor: A report of two cases with novel genetic findings	5
The orphan nuclear receptor NR0B2 could be a novel susceptibility locus associated with microsatellite‐stable, APC mutation‐negative early‐onset colorectal carcinom	5
Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor	5
ZFP64::NCOA3 gene fusion defines a novel subset of spindle cell rhabdomyosarcoma	5
Ewing sarcoma and related FET family translocation‐associated round cell tumors: A century of clinical and scientific progress	5
UBTF‐internal tandem duplication as a novel poor prognostic factor in pediatric acute myeloid leukemia	5
Expanding the molecular spectrum of gene fusions in endometrial stromal sarcoma: Novel subunits of the chromatin remodeling complexes PRC2 and NuA4/TIP60 as alternativ	5
A case of FN1‐fused calcified chondroid mesenchymal neoplasm of the hand with novel FGFR3 partner gene	5
NUTM1‐fusion positive malignant neoplasms of the genitourinary tract: A report of six cases highlighting involvement of unusual anatomic locations and histologic heterogeneity	5
POU2AF3‐rearranged sarcomas: A novel tumor defined by fusions of EWSR1 or FUS to a gene formerly designated COLCA2	5
Sister chromatid cohesion defects are associated with chromosomal copy number heterogeneity in high hyperdiploid childhood acute lymphoblastic leukemia	5
Neuregulin 1 (NRG1) fusion‐positive high‐grade spindle cell sarcoma: A distinct group of soft tissue tumors with metastatic potential	5
RBM10‐TFE3 fusions: A FISH‐concealed anomaly in adult renal cell carcinomas displaying a variety of morphological and genomic features: Comprehensive study of six novel cases	5
Tyrosine kinase‐altered spindle cell neoplasms with EGFR internal tandem duplications	4
Malignant undifferentiated epithelioid neoplasms with MAML2 rearrangements: A clinicopathologic study of seven cases demonstrating a heterogenous entity	4
FGFR2::TACC2 fusion as a novel KIT‐independent mechanism of targeted therapy failure in a multidrug‐resistant gastrointestinal stromal tumor	4
A YAP1::TFE3 cutaneous low‐grade fibromyxoid neoplasm: A novel entity!	4
Prognostic impact of copy number alterations and tumor mutational burden in carcinoma of unknown primary	4
Tumor‐only sequencing for oncology management: Germline‐focused analysis and implications	4
A cloud‐based resource for genome coordinate‐based exploration and large‐scale analysis of chromosome aberrations and gene fusions in cancer	4
No evidence of EMAST in whole genome sequencing data from 248 colorectal cancers	4
Histology‐based molecular profiling improves mutation detection for advanced thyroid cancer	4
Cryptic TCF3 fusions in childhood leukemia: Detection by RNA sequencing	4
MDM4 amplification in atypical lipomatous tumors/well‐differentiated liposarcoma: Private event or alternative oncogenic mechanism?	4
An unusual fusion gene EML4‐ALK in a patient with congenital mesoblastic nephroma	4
Gene fusions in gastrointestinal tract cancers	4
A novel fusion variant LSM14A::NR4A3 in extraskeletal myxoid chondrosarcoma	4
Upfront progression under pembrolizumab followed by a complete response after encorafenib and cetuximab treatment in BRAF V600E‐mutated and microsatellite unstable metastatic colorectal can	4

Real‐world data for precision cancer medicine—A European perspective	4
Germline SDHB‐inactivating mutation in gastric spindle cell sarcoma	4
Dramatic response to entrectinib in a patient with malignant peripheral nerve sheath tumor harboring novel SNRNP70‐NTRK3 fusion gene	4
Expanding the spectrum of mesenchymal neoplasms with NR1D1‐rearrangement	3
Novel MEAF6‐SUZ12 fusion in ossifying fibromyxoid tumor with unusual features	3
Ultra‐low depth sequencing of plasma cell DNA for the detection of copy number aberrations in multiple myeloma	3
Fusion‐positive skin/adnexal carcinomas	3
The novel KIT exon 11 germline mutation K558N is associated with gastrointestinal stromal tumor, mastocytosis, and seminoma development	3
Assessing acute myeloid leukemia susceptibility in rearrangement‐driven patients by DNA breakage at topoisomerase II and CCCTC‐binding factor/cohesin binding sites	3
EGFR internal tandem duplications in fusion‐negative congenital and neonatal spindle cell tumors	3
A versatile system to introduce clusters of genomic double‐strand breaks in large cell populations	3
Establishment and characterization of a MALT lymphoma cell line carrying an API2‐MALT1 translocation	3
Untying the Gordian knot of composite hemangioendothelioma: Discovery of novel fusions	3
ERG amplification is a secondary recurrent driver event in myeloid malignancy with complex karyotype and TP53 mutations	3
Computational methods and translational applications for targeted next‐generation sequencing platforms	3
Treatment outcomes and prognosis of patients with primary and acquired BRAF‐mutated non‐small cell lung cancer: A multicenter retrospective study	3
Lateralized overgrowth with vascular malformation caused by a somatic PTPN11 pathogenic variant: Another piece added to the puzzle of mosaic RASopathies	3
Recurrent chromosomal imbalances provide selective advantage to human embryonic stem cells under enhanced replicative stress conditions	3
A novel IRF2BP2::CDX2 Gene fusion in digital intravascular myoepithelioma of soft tissue: An enigma!	3
Soft‐tissue sarcoma with MN1‐BEND2 fusion: A case report and comparison with astroblastoma	3
Inactivation of RB1, CDKN2A, and TP53 have distinct effects on genomic stability at side‐by‐side comparison in karyotypically normal cells	3
Comprehensive analyses of microRNA and mRNA expression in colorectal serrated lesions and colorectal cancer with a microsatellite instability phenotype	3
A novel HNRNPH1::ERG rearrangement in aggressive acute myeloid leukemia	3
A novel PPP2R2A::PRKD1 fusion in a cribriform adenocarcinoma of salivary gland	3
GAB1::ABL1 fusions define a distinctive soft tissue neoplasm, with variable perineurial differentiation, and a predilection for children and young adults	3
Aneurysmal bone cyst with an unusual clinical presentation and a novel VDR‐USP6 fusion	3
VIM::KMT2A‐rearranged sarcomas: A report of two new cases confirming an entity with distinct histologic features	3
A novel low‐grade nasopharyngeal adenocarcinoma characterized by a GOLGB1‐BRAF fusion gene	3
Metastatic sporadic paraganglioma with EWSR1::CREM gene fusion: A unique molecular profile that expands the phenotypic diversity of the molecular landscape of the EWSR1::CREM gene fusion	3
Machine learning in computational histopathology: Challenges and opportunities	3
TP53 and RB1 alterations characterize poor prognostic subgroups in pediatric acute myeloid leukemia	2
Digital pathology systems enabling quality patient care	2
Clinical and genomic characterization of an ATRA‐insensitive acute promyelocytic leukemia variant with a FNDC3B::RARB fusion	2
PARP inhibition in prostate cancer	2
Glioblastoma with novel EGFR mutations (T790M and exon 20 insertion) yet unresponsive to osimertinib: A case report	2
The clinicopathologic significance of NPM1 mutation and ability to detect mutated NPM1 by immunohistochemistry in non‐AML myeloid neoplasms	2
Ovarian germ cell tumor/mastocytosis with KIT mutation: A unique clinicopathological entity	2
ZFTA::RELA fusion in a distinct liposarcoma morphologically overlapping with chondroid lipoma	2
Low‐grade endometrial stromal sarcoma‐like tumors in male with JAZF1 gene fusions	2
SFPQ‐ABL1‐positive B‐cell precursor acute lymphoblastic leukemias	2
The novel finding of an FGFR1::TACC1 fusion in an undifferentiated spindle cell sarcoma of soft tissue with aggressive clinical course	2
An SS18::NEDD4 cutaneous spindled and epithelioid sarcoma: An hitherto unclassified cutaneous sarcoma, resembling epithelioid sarcoma with aggressive clinical behavior	2
Loss of ALK hotspot mutations in relapsed neuroblastoma	2
CRLF2 overexpression defines an immature‐like subgroup which is rescued through restoration of the PRC2 function in T‐cell precursor acute lymphoblastic leukemia	2
Significance of distinguishing 3′‐IGH deletion from 5′‐IGH deletion in multiple myeloma	2
Mutations involving TGFB and MAPK may be associated with malignancy in granular cell tumors	2
Germline sequence analysis of RABL3 in a large series of pancreatic ductal adenocarcinoma patients reveals no evidence of deleterious variants	2
A cryptic EWSR1::DDIT3 fusion in myxoid liposarcoma: Potential pitfalls with FISH and cytogenetics	2
How to use AI in pathology	2
BRAFmutations and concurrent alterations in patients with soft tissue sarcoma	2
Uncovering variable neoplasms between ATM protein‐truncating and common missense variants using 394 694 UK Biobank exomes	2
Primary NTRK‐rearranged spindle cell  neoplasm of bone harboring an HMBOX1::NTRK3 gene fusion	2
Case of epithelioid hemangioendothelioma occurring in the postradiation setting for breast cancer	2
Myoepithelial carcinoma of the parotid gland with a novel CTCF::NCOA2 fusion	2
Loss of smarcad1a accelerates tumorigenesis of malignant peripheral nerve sheath tumors in zebrafish	2
Generation of pralatrexate resistant T‐cell lymphoma lines reveals two patterns of acquired drug resistance that is overcome with epigenetic modifiers	2
AGAP3: A novel BRAF fusion partner in pediatric pancreatic‐type acinar cell carcinoma	2
Primary renal sarcoma with SS18::POU5F1 gene fusion	2
A novel STRN3::PRKD1 fusion in a cribriform adenocarcinoma of salivary gland with high‐grade transformation	2
MicroRNA‐192‐5p inhibits migration of triple negative breast cancer cells and directly regulates Rho GTPase activating protein 19	2
MLH1 epimutation is a rare mechanism for Lynch syndrome: A case report and review of the literature	2
Unbalanced translocation der(5;17) resulting in a TP53 loss as recurrent aberration in myelodysplastic syndrome and acute myeloid leukemia with complex karyotype	2
Amplification of ERBB2 (HER2) in embryonal rhabdomyosarcoma: A potential treatment target in rare cases?	2
Increased MYB alternative promoter usage is associated with relapse in acute lymphoblastic leukemia	2
Primary mediastinal large B‐cell lymphoma is characterized by large‐scale copy‐neutral loss of heterozygosity	2
Rare and novel RUNX1 fusions in myeloid neoplasms: A single‐institute experience	2
Rare germline variants in childhood cancer patients suspected of genetic predisposition to cancer	2
Design of a targeted next‐generation DNA sequencing panel for pediatric T‐cell lymphoblastic lymphoma to unravel biology and optimize treatment	2
Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology	2
Identification of a novel PHIP::BRAF gene fusion in infantile fibrosarcoma	2